Importantly, our previous work [36] showed that PRIMA-1Met reactivates p53 regardless of the mechanism causing its deactivation, thereby inhibiting PI3K signaling and sensitizing (V600E/K) BRAF-positive melanoma cells to BRAF inhibitors. Here, BRAF is linked to melanoma.